Posts tagged newborn sequencing
#465: Personalizing GLP-1 Medications: The Role of Genetics in Weight Loss and Side Effects With Noura Abul-Husn M.D. Ph.D
#465: Personalizing GLP-1 Medications: The Role of Genetics in Weight Loss and Side Effects With Noura Abul-Husn M.D. Ph.D

Today, I’m joined by the incredible Dr. Nora Abdul-Hussein, a physician-scientist, medical geneticist, and one of the leading voices in the field of genomic medicine. In this episode, Dr. Abdul-Hussein and I dig into a huge question—why do two people taking the exact same GLP-1 medication have such wildly different results, from weight loss to side effect profiles? She shares her unique path from internal medicine to cutting-edge population genomics, and how her work at 23andMe is beginning to answer some of medicine’s toughest puzzles.

Read More
GLP-1s & Peptides, Weight Loss, Genetics & GenomicsLorenz Ralph GañoGLP-1 medications, weight loss, pharmacogenomics, genetic variants, personalized medicine, genetic predisposition, type 2 diabetes, nausea and vomiting, side effects, GLP-1 receptor gene, GIP receptor gene, semaglutide, tirzepatide, genome-wide association study, pharmacogenetics, polygenic risk score, genetic ancestry, healthspan, longevity, metabolic health, prevention, biomarkers, ancestry testing, 23andMe, personalized interventions, clinical trials, obesity stigma, actionable genes, newborn sequencing, data privacy